Navigation Links
UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
Date:12/7/2012

e cancer center, and as such is ideally suited for this type of collaboration."

The institute is a vital platform resource for MD Anderson's recently announced and unprecedented Moon Shots Program, which focuses resources and diverse expertise to significantly reduce mortality in the short term and promote cures long term, beginning with eight inaugural cancers.

Unleashing the immune system

Malignant cells are an abnormality that usually attracts a response from the body's immune system, yet cancer often survives by evading or thwarting anti-tumor immunity. Consistently unleashing the power of the immune system against cancer would be a major step forward for cancer patients.

T cells are lymphocytes, a type of white blood cell produced by the thymus, equipped with receptors that recognize and bind to antigens, which may include abnormal cells.

"T cell recognition of a tumor antigen is not enough to activate the T cells against cancer cells, they need a secondary signal to tell them 'that antigen you have is a bad thing, you have to attack,'" said Liu, who is now chief scientific officer and vice president of the Baylor Research Institute of the Baylor Health Care System in Dallas.

OX40 is one of these secondary or co-stimulatory receptor proteins. Liu and colleagues found that when it's activated, it enhances immune attack and blocks suppressors of immune response.

Liu and his MD Anderson colleagues generated and screened hundreds of antibodies that could potentially act as on switches for OX40 by mimicking its natural activator, OX40L, a molecule that binds to OX40. Years of research narrowed the candidates to a handful of activators, or agonists, which were tested in mice and then altered for human use.

"It's gratifying to see MD Anderson and GSK take this important step towards translating a basic science discovery into a potential new therapy that can proceed to clinical trial," Liu
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases
2. Journals and pharma collaborate on new recommendations
3. ICA Fellow, Dafna Lemish, collaborates with UNICEF on child development initiative
4. Springer and the Breast Cancer Research Foundation to collaborate on book series
5. ACP and WellPoint collaborate to give physicians the tools they need to participate in PCMH programs
6. CWRU dental and nursing students collaborate for one-stop healthcare
7. Organizations collaborate to support research on arthritis and aging
8. ACP and NACHC collaborate to help federally-qualified heath centers improve care
9. FDA to Collaborate on Development of Medical Devices
10. University of Southern Mississippi Professor Collaborates with Houston Police for Eyewitness Research Study
11. Unique approach needed to accurately assess health of young adult cancer survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT MD Anderson, GlaxoSmithKline to collaborate on new approach to cancer immune therapy
(Date:9/2/2014)... 03, 2014 Recently, Top 10 ... companies and announced that JustHost ( http://www.justhost.com/track/seohosts ) ... webmasters. , “The hosting suppliers we recommend are ... competitors on hosting features, uptime and server speed ... Best SEO Hosting says. “We believe that BlueHost ...
(Date:9/2/2014)... The exciting information sessions and AMTC ... Carey Lewis and Bob Wiley. The team of ... have the desire to illuminate entertainment with the light ... be invited to join the Bridge Training Program ... Saturday, Sept. 6, Charlotte Convention Center, 501 South College ...
(Date:9/2/2014)... Washington, DC (PRWEB) September 02, 2014 TCG, ... named by Inc. 5000 as one of the fastest-growing companies ... the eighth time total. TCG was previously recognized in 2013, ... 2001. , TCG’s revenue has grown 86% from 2010 to ... of the fastest growing businesses in America - up 635 ...
(Date:9/2/2014)... 02, 2014 Friendship Village of ... “This creates a contemporary marketing presence and ... its parent organization, Friendship Senior Options,” said Stephen ... Options. “By changing the logo, we are making ... to seniors and their families.” , Friendship Village ...
(Date:9/2/2014)... September 02, 2014 Cloud Medical Doctor ... “Cloud Based” Medical Practice Business Operations solutions and Billing ... Digital Cyber Security solutions for all industries announced today ... the trading floor of the CME in Chicago by ... stated that we are very proud of the recognition ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Auditions Are Set for Charlotte and Omaha on Saturday, September 6, 2014 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3
... the recent economic downturn, natural health degree ... still experiencing a wellness boom, as holistic ... the Internet,s top natural health career site ... training, chiropractic, nutrition, Reiki and reflexology career ...
... Upsher-Smith announces the launch of www.prenexa.com , a web site ... with more plant-based DHA (docosahexaenoic acid) than any other prenatal vitamin. ... ... Upsher-Smith announces the launch of prenexa.com, a web site devoted to ...
... from the Dutch Health Insurance System model, according to an ... of the Journal of Health Politics, Policy and Law ... at The University of Texas School of Public Health at ... coverage in the Netherlands and its possible lessons for the ...
... prevention and treatment for people living with HIV/AIDS. , ... ... annual World AIDS Day , global health activists gathered for ... today that nearly 6,000 people from 163 countries signed a petition ...
... SAN FRANCISCO, Dec. 8 Quantros, a leading ... healthcare industry, today,announced that the Agency for Healthcare ... Quantros Patient Safety Center as a Patient Safety,Organization ... . The Quantros Patient Safety Center,is a new ...
... iron from the heart in beta-thalassemia patients with mild to severe ... a subgroup analysis of 341 patients with myelodysplastic syndromes (MDS), Exjade ... -These results are part of the largest prospective trial ... transfusion-dependent anemias , , EAST HANOVER, ...
Cached Medicine News:Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 2Health News:Natural Healers Researches Natural Health Careers to Make the Prospective Holistic Health Students' Job Easier 3Health News:Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health 2Health News:Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health 3Health News:UT public health policy expert says US can learn from Dutch universal health-care coverage 2Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 2Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 3Health News:Thousands Sign Petition for Action on HIV/AIDS and Malaria 4Health News:Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO) 2Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 2Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 3Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 4Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 5Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 6Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 7Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 8Health News:Exjade(R) Benefits Chronically Transfused Patients by Significantly Reducing Toxic Iron That Can Damage Key Organs, According to Landmark Trial 9
(Date:9/2/2014)... 2, 2014    - ... muestran agentes antitrombóticos no utilizados óptimamente para prevenir ... Las presentaciones de GARFIELD-AF en el ESC CONGRESS ... los resultados de pacientes en riesgo de sufrir ... Los datos de casi 12.500 pacientes ...
(Date:9/2/2014)... 2, 2014 , ... provide insight into treatment and outcomes of patients ... --   Data from nearly 12,500 ... the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic ... for atrial fibrillation (AF) patients remain sub-optimal despite ...
(Date:9/2/2014)... -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... at the Morgan Stanley Global Healthcare Conference in ... September 9, 2014 , Presentation time: 5:15 p.m. ET ... of this presentation will be available at http://ir.avanir.com . ... Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative ...
Breaking Medicine Technology:Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9
... is the principal hormone responsible for the control ... the b-cells of the islets of Langerhans as ... C-peptide and insulin. Both are secreted in ... mature insulin molecule is comprised of two polypeptide ...
Calcitonin EIA Bone and Mineral Metabolism 021-SDX017...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-96 Proteinase...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
Medicine Products: